2022
DOI: 10.18773/austprescr.2022.048
|View full text |Cite
|
Sign up to set email alerts
|

Letter to the Editor: Drospirenone and mood

Abstract: I read with interest the article 'Hormonal contraception and mood disorders', but noted that it overlooked the 4 mg drospirenone 24/4 progestogen-only pill (Slinda). 1 The article also did not consider the 20 microgram ethinylestradiol/3 mg drospirenone preparation which has an indication for treatment of premenstrual dysphoric disorder.Perhaps the authors might consider that the benefits shown in their pilot study may be due to a 24/4 preparation (also noted in the studies referenced in reducing pill-free in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 3 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?